Clinical Trial Update: A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG) [Phase 1, Phase 2]

View source ↗

Summary

A pilot study using [18F] Fluorodeoxyglucose (FDG) to treat malignant tumors (Phase 1/Phase 2) has been suspended. The trial is sponsored by Weill Medical Colle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Fluorodeoxyglucose (FDG) (Fluorodeoxyglucose)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Advanced Cancer | Phase 1, Phase 2 | Status: SUSPENDED